Earnings Bharat Petroleum Corporation Q4 FY23 (Consolidated, YoY) Revenues up 8% at Rs 1,33,419.56 crore (Bloomberg estimate: Rs 1,28,782.43 crore) Ebitda up 85.42% at Rs 11,084.79 crore (Bloomberg estimate: Rs 5,611.35 crore) Ebitda margin at 9.38% vs 5.73% (Bloomberg estimate: 4.4%) Net profit up 168.46% at Rs 6,870.47 crore (Bloomberg estimate: Rs 3,242.93 crore) The company will pay a dividenof Rs 4 per share for the fiscal 2022-23, subject to shareholders’ approval.

Shree Cement Q4 FY23 (Consolidated, YoY) Revenue up 16.86% at Rs 5,100.19 crore (Bloomberg estimate: Rs 4,763.90 crore) Ebitda down 3.22% at Rs 889.20 crore (Bloomberg estimate: Rs 959.54 crore) Ebitda margin at 17.43% vs 21.05% (Bloomberg estimate: 20.1%) Net profit down 20% at Rs 525.77 crore (Bloomberg estimate: Rs 438.50 crore) The board declared an interim dividend of Rs 55 per share for thefiscal 2023. The record date for the dividend is June 1 and it will be paid from June 13.
Finolex Industries Q4 FY23 (Consolidated, YoY) Revenues down 28.44% at Rs 1,141.06 crore (Bloomberg estimate: Rs 1,321.1 crore) Ebitda down 17.85% at Rs 217.43 crore (Bloomberg estimate: Rs 177.06 crore) Ebitda margin at 19.06% vs 16.6% (Bloomberg estimate: 13.4%) Net profit down 66.37% at Rs 166.5 crore (Bloomberg estimate: Rs 137.83 crore) The company had benefited from exceptional gains to the tune of Rs 376.06 crore in the year-ago period. The board declared a final dividend of Rs 1.50 per share for the fiscal 2023.

Source - https://www.bqprime.com/markets/stocks-to-watch-vedanta-biocon-nmdc-bpcl-max-healthcare-iti-jsw-energy